The CEO of FibroBiologics describes the idea of using fibroblasts rather than stem cells for regenerative medicine and chronic diseases

blonca9
Jun 6, 2024
1 min read

Pete O'Heeron makes the case for fibroblasts and describes FibroBiologics's clincal MS program and upcoming ones for diabetic wound care and degenerative disc disease.

Recent Posts

See All

Stanford professor James Zou and his team created a virtual lab with AI scientists - they designed nanobodies for a COVID variant

William Blair Senior Biotech Analyst Andy Hsieh reacts to today's oral obesity data from Viking's VK2735 and recent data from Lilly's orforglipron

AI News: While most AI in healthcare is aimed at helping physicians better diagnose and treat disease, CureWise is built for patients to help understand their conditions and ask the right questions

The CEO of FibroBiologics describes the idea of using fibroblasts rather than stem cells for regenerative medicine and chronic diseases

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight